Literature DB >> 8826170

Epidural analgesia in labor: an evaluation of risks and benefits.

J A Thorp, G Breedlove.   

Abstract

BACKGROUND: Intrapartum epidural analgesia has become increasingly popular because it is the most effective method of providing pain relief during labor. Much attention is given to its safety and efficacy, and many health care providers and consumers are unaware of its potential drawbacks. This article reviews the literature about the effects of epidural analgesia on the mother and infant.
METHODS: We performed a computer-assisted MEDLINE search for articles and a review of bibliographies from articles on epidural analgesia. When reported data were incomplete, authors were contacted for more detailed information.
RESULTS: The most common procedure-related complications, hypotension, inadvertent dural puncture, and headache, are easily treated and usually self-limited. Permanent morbidity and mortality are rare. Retrospective studies and randomized controlled trials both demonstrate that epidural analgesia is associated with increases in duration of labor, instrument vaginal delivery, and cesarean birth. To date only three trials randomized patients to narcotic versus epidural groups, and all showed a twofold to threefold increase in cesarean section for dystocia. Limiting epidural use in nulliparous labor and delaying its placement until after 5 cm of cervical dilation may reduce the risk of operative intervention for dystocia. Epidural analgesia may also increase intervention for fetal distress. Several studies show its association with maternal fever in labor. Its association with chronic back pain, neonatal behavioral changes, and maternal-infant bonding are more tenuous and require further study.
CONCLUSIONS: Epidural analgesia is a safe and effective method of relieving pain in labor, but is associated with longer labor, more operative intervention, and increases in cost. It must remain an option; however, caregivers and consumers should be aware of associated risks. Women should be counseled about these risks and other pain-relieving options before the duress of labor.

Entities:  

Mesh:

Year:  1996        PMID: 8826170     DOI: 10.1111/j.1523-536x.1996.tb00833.x

Source DB:  PubMed          Journal:  Birth        ISSN: 0730-7659            Impact factor:   3.689


  7 in total

1.  Exploring Women's Preferences for Labor Epidural Analgesia.

Authors:  Mary Ann Stark
Journal:  J Perinat Educ       Date:  2003

Review 2.  Pushing/bearing down methods for the second stage of labour.

Authors:  Andrea Lemos; Melania Mr Amorim; Armele Dornelas de Andrade; Ariani I de Souza; José Eulálio Cabral Filho; Jailson B Correia
Journal:  Cochrane Database Syst Rev       Date:  2017-03-26

3.  Maternal intrapartum temperature elevation as a risk factor for cesarean delivery and assisted vaginal delivery.

Authors:  E Lieberman; A Cohen; J Lang; F Frigoletto; L Goetzl
Journal:  Am J Public Health       Date:  1999-04       Impact factor: 9.308

Review 4.  Pain management for women in labour: an overview of systematic reviews.

Authors:  Leanne Jones; Mohammad Othman; Therese Dowswell; Zarko Alfirevic; Simon Gates; Mary Newburn; Susan Jordan; Tina Lavender; James P Neilson
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

5.  Risk factors associated with epidural use.

Authors:  Samuel M Lancaster; Ursula M Schick; Morwan M Osman; Daniel A Enquobahrie
Journal:  J Clin Med Res       Date:  2012-03-23

6.  Administration of epidural labor analgesia is not associated with a decreased risk of postpartum depression in an urban Canadian population of mothers: a secondary analysis of prospective cohort data.

Authors:  Marissa Nahirney; Amy Metcalfe; Katie H Chaput
Journal:  Local Reg Anesth       Date:  2017-10-31

7.  Comparison of Continuous Epidural Infusion of Bupivacaine and Fentanyl Versus Patient Controlled Analgesia Techniques for Labor Analgesia: A Randomized Controlled Trial (RCT).

Authors:  Raha Khaneshi; Sousan Rasooli; Farnaz Moslemi; Sanam Fakour
Journal:  J Reprod Infertil       Date:  2020 Jan-Mar
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.